Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with ABVD for Newly Diagnosed Advanced Hodgkin Lymphoma
NCT00722865Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2008
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in classical Hodgkin lymphoma (cHL), sponsored by Massachusetts General Hospital. Started Sep 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT00722865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722865.